Ontario Pharmacy Practice Update Page

COVID-19 Outpatient Treatment: How Confident are you?

In Dec 2022 Ontario authorized community pharmacists to prescribe oral nirmatrelavir/ritonavir (Paxlovid) to high-risk patients with moderate illness to reduce severe disease and hospitalization. As the “medication experts” in healthcare, pharmacists have the perfect knowledge to support patients in Canada’s largest province. Some pharmacists feel comfortable prescribing Paxlovid to community patients, while others do not.

Take the COVID-19 outpatient treatment challenge below to determine how confident you are with prescribing in your practice.

View Course

Please click on the image to view course on your mobile device.